Desmopressin responsiveness in children with Ehlers-Danlos syndrome associated bleeding symptoms

British Journal of Haematology

Volumn 144, Issue 2, 2009, Pages 230-233

  Mast, Kelley J ^a   Nunes, Mark E ^a,b   Ruymann, Frederick B ^a,b   Kerlin, Bryce A ^a,b,c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Bleeding time; Coagulopathy; Desmopressin; Ehlers Danlos; Hypermobility

Indexed keywords

DESMOPRESSIN; DESMOPRESSIN ACETATE;

ARTICLE; BLEEDING; BLEEDING TIME; DISEASE ASSOCIATION; EHLERS DANLOS SYNDROME; FACIAL FLUSHINH; FLUSHING; HEADACHE; HUMAN; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; BLEEDING TIME; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; EHLERS-DANLOS SYNDROME; FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 58149098555     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07446.x     Document Type: Article

References (15)

1. Anstey, A., Mayne, K., Winter, M., Van de Pette, J. Pope, F.M. (1991) Platelet and coagulation studies in Ehlers-Danlos syndrome. British Journal of Dermatology, 125, 155 163.
2. Beighton, P., De Paepe, A., Steinmann, B., Tsipouras, P. Wenstrup, R.J. (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). American Journal of Medical Genetics, 77, 31 37.
3. Bolton-Maggs, P.H., Perry, D.J., Chalmers, E.A., Parapia, L.A., Wilde, J.T., Williams, M.D., Collins, P.W., Kitchen, S., Dolan, G. Mumford, A.D. (2004) The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia, 10, 593 628.
4. Cesar, J.M., de Miguel, D., Garcia Avello, A. Burgaleta, C. (2005) Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. American Journal of Clinical Pathology, 123, 772 777.
5. De Paepe, A. Malfait, F. (2004) Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. British Journal of Haematology, 127, 491 500.
6. Favaloro, E.J. (2006) The utility of the PFA-100 in the identification of von Willebrand disease: a concise review. Seminars in Thrombosis and Hemostasis, 32, 537 545.
7. Grahame, R., Bird, H.A. Child, A. (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). Journal of Rheumatology, 27, 1777 1779.
8. Hedner, U. (1975) Letter: platelet aggregating properties of Ehlers-Danlos syndrome "collagen". Thrombosis et Diathesis Haemorrhagica, 33, 380 381.
9. Lawrence, E.J. (2005) The clinical presentation of Ehlers-Danlos syndrome. Advances in Neonatal Care, 5, 301 314.
10. Mannucci, P.M. (1998) Hemostatic drugs. New England Journal of Medicine, 339, 245 253.
11. Nuss, R. Manco-Johnson, M. (1995) Hemostasis in Ehlers-Danlos syndrome. Patient report and literature review. Clinical Pediatrics (Phila), 34, 552 555.
12. Pyeritz, R.E. (2000) Ehlers-Danlos syndrome. New England Journal of Medicine, 342, 730 732.
13. Rochelson, B., Caruso, R., Davenport, D. Kaelber, A. (1991) The use of prophylactic desmopressin (DDAVP) in labor to prevent hemorrhage in a patient with Ehlers-Danlos syndrome. New York State Journal of Medicine, 91, 268 269.
14. Stine, K.C. Becton, D.L. (1997) DDAVP therapy controls bleeding in Ehlers-Danlos syndrome. Journal of Pediatric Hematology/Oncology, 19, 156 158.
15. Yasui, H., Adachi, Y., Minami, T., Ishida, T., Kato, Y. Imai, K. (2003) Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndrome. American Journal of Hematology, 72, 71 72.